Short Interest in Vimian Group AB (publ) (OTCMKTS:VIMGF) Drops By 43.1%

Vimian Group AB (publ) (OTCMKTS:VIMGF) saw a significant decline in short interest in the month of August. As of August 31st, there was short interest totalling 1,413,100 shares, a decline of 43.1% from the August 15th total of 2,483,000 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is presently 14,131.0 days.

Vimian Group AB (publ) Price Performance

Shares of VIMGF stock opened at C$4.12 on Friday. Vimian Group AB has a 12 month low of C$2.68 and a 12 month high of C$4.12. The company has a 50 day simple moving average of C$3.16 and a two-hundred day simple moving average of C$2.76.

About Vimian Group AB (publ)

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.